Knight Initiative News

This week on From Our Neurons to Yours, we talk with Stanford neurologist Mike Greicius about his critique of new amyloid-clearing Alzheimer's drugs, and his optimism for the next wave of therapies currently in development.

Research by Kati Andreasson and colleagues suggests that a type of drug developed for treating cancer may hold promise as a new treatment for neurodegenerative disorders such as Alzheimer’s.

A drug that restores brain metabolism in mouse models of Alzheimer's also improved cognitive function, according to research from the Andreasson lab.

A team of neuroscientists at the Knight Initiative for Brain Resilience have zeroed in on a critical regulator of brain metabolism that may be over-activated in the brains of patients with Alzheimer’s disease.

Institute affiliates Brad Zuchero, Justin Du Bois and colleagues discovered that neurons require signaling from glia to become fully excitable, rather than by becoming excitable by default.

Time marches on predictably, but biological aging is anything but constant, according to new research by Michael Snyder and colleagues.

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

This week on From Our Neurons to Yours, we talk with Sergiu Pasca about using new techniques for growing human brain tissue in the lab to solve a rare neurological disorder.

This week, we talk with Zhenan Bao about reverse engineering the remarkable properties of human skin to design new wearable devices for neuroscience.

At the 2024 Neuro-omics Symposium, early-stage research funded by Wu Tsai Neuro's Big Ideas in Neuroscience program revealed exciting progress at the intersection of genomics and AI.

New software developed by the NeuroPlant Big Ideas in Neuroscience initiative turns an ordinary flatbed scanner and collection of nematode worms into a DIY platform to sniff out both beneficial and harmful plant-based molecules.

Ten early career neuroscientists received the prestigious award from The McKnight Endowment Fund for Neuroscience.

A research team at Stanford’s Wu Tsai Neurosciences Institute has made a major stride in using AI to replicate how the brain organizes sensory information to make sense of the world, opening up new frontiers for virtual neuroscience.

Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.

Pro-inflammatory protein TREM1 in peripheral immune cells may promote age-related cognitive decline and dementia, according to Knight Initiative–funded research.

Wu Tsai Neuro research suggests giant genes could hold the key to the development of complex nervous systems across the animal kingdom.

New research supported by Wu Tsai Neurosciences Institute could lead to novel treatments for demyelinating disorders such as multiple sclerosis.

Recent research supported by the Knight Initiative has identified a link between lipid droplets in the microglia to a known genetic risk factor for AD.

Two new studies supported by the Knight Initiative highlight groundbreaking new early biomarkers for the diagnosis and treatment of neurodegenerative disease.

This week, we sit down with neuroscientist Tony Wyss-Coray to learn about how some of your organs may be aging faster than the rest of you.